Policy changes Backwork has recorded, newest first. The most recent change on record is from October 2, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,180 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Minimally Invasive Ablation Procedures for Morton and Other Peripheral Neuromas | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Microwave Tumor Ablation | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Microprocessor-Controlled Prostheses for the Lower Limb | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Meniscal Allografts and Other Meniscus Implants | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Measurement of Serum Antibodies to Selected Biologic Agents | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Magnetic Resonance Imaging (MRI) of the Breast | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Lyfgenia | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Luxturna | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Lumbar Spinal Fusion | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Low-Level Laser Therapy | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Low Intensity Pulsed Ultrasound Fracture Healing Device | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Lenmeldy (atidarsagene autotemcel) | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Leadless Cardiac Pacemakers | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Laboratory Tests Post Transplant and for Heart Failure | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Kresladi | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Kebilidi (eladocagene exuparvovec-tneq) (Intraputaminal) | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Itvisma | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Intra-Articular Hyaluronan Injections for Osteoarthritis | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Interventions for Progressive Scoliosis | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Implanted Peripheral Nerve Stimulator (PNS) for Pain Control | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Implantable Cardioverter Defibrillators | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Implantable Bone-Conduction and Bone-Anchored Hearing Aids | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Identification of Microorganisms Using Nucleic Acid Testing | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Hydrogel Spacer use During Radiotherapy for Prostate Cancer | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Human Growth Hormone | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Homocysteine Testing | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Home Non-invasive Positive Airway Pressure Devices for the Treatment of Respiratory Insufficiency and Failure | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Hemgenix | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2) | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Breast Cancer (BRCA1, BRCA2, PIK3CA, Ki-67, RET, BRAF, ESR1, NTRK) | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Variant Testing (Including Liquid Biopsy) for Targeted Treatment in Advanced Cancer and Metastatic Cancer | New policy |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathies | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Testing for Predisposition to Inherited Hypertrophic Cardiomyopathy | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related Disorders | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Testing for Diagnosis and Management of Mental Health Conditions | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Testing for Cardiac Ion Channelopathies | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Cancer Susceptibility Panels Using Next Generation Sequencing | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Advanced Cancer | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Gene Expression Profiling, Protein Biomarkers, and Multimodal Artificial Intelligence for Prostate Cancer Management | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Gene Expression Profiling for Cutaneous Melanoma | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Gastric Electrical Stimulation | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Filsuvez Medical Drug Criteria | Metadata changed |
| Sep 30, 2026 | Blue Cross and Blue Shield of Kansas | Facet Joint Denervation | Metadata changed |